![TBV TBV](https://data.pdbj.org/pdbjplus/data/cc/svg/TBV.svg) | TBV | 表記: | 3-[2-[[3-(2-CARBOXYETHYL)-5-[[3-ETHENYL-4-METHYL-5-[(2-METHYLPROPAN-2-YL)OXY]-1H-PYRROL-2-YL]METHYL]-4-METHYL-1H-PYRROL
-2-YL]METHYL]-5-[(Z)-(4-ETHENYL-3-METHYL-5-OXO-PYRROL-2-YLIDENE)METHYL]-4-METHYL-1H-PYRROL-3-YL]PROPANOIC ACID | 組成式: | C37 H46 N4 O6 | SMILES: | Cc1c(Cc2[nH]c(OC(C)(C)C)c(C)c2C=C)[nH]c(Cc3[nH]c(C=C4NC(=O)C(=C4C)C=C)c(C)c3CCC(O)=O)c1CCC(O)=O | InChi: | InChI=1S/C37H46N4O6/c1-10-23-22(6)36(47-37(7,8)9)41-30(23)17-28-21(5)26(13-15-34(44)45)32(39-28)18-31-25(12-14-33(42)43)20(4)27(38-31)16-29-19(3)24(11-2)35(46)40-29/h10-11,16,38-39,41H,1-2,12-15,17-18H2,3-9H3,(H,40,46)(H,42,43)(H,44,45)/b29-16- | 別名: | BILIVERDIN | 定義日: | 2009-03-19 | 最終更新日: | 2020-06-17 | 識別子(ID): | 3-[2-[[3-(2-carboxyethyl)-5-[[3-ethenyl-4-methyl-5-[(2-methylpropan-2-yl)oxy]-1H-pyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid |
|
![PPE PPE](https://data.pdbj.org/pdbjplus/data/cc/svg/PPE.svg) | PPE | 表記: | 4-[(1,3-DICARBOXY-PROPYLAMINO)-METHYL]-3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDINIUM | 組成式: | C13 H20 N2 O9 P | SMILES: | O=C(O)C(NCc1c(c[nH+]c(c1O)C)COP(=O)(O)O)CCC(=O)O | InChi: | InChI=1S/C13H19N2O9P/c1-7-12(18)9(8(4-14-7)6-24-25(21,22)23)5-15-10(13(19)20)2-3-11(16)17/h4,10,15,18H,2-3,5-6H2,1H3,(H,16,17)(H,19,20)(H2,21,22,23)/p+1/t10-/m0/s1 | 別名: | PYRIDOXYL-GLUTAMIC ACID-5'-MONOPHOSPHATE | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridinium-4-yl}methyl)-L-glutamic acid |
|
![PBG PBG](https://data.pdbj.org/pdbjplus/data/cc/svg/PBG.svg) | PBG | 表記: | 3-[5-(AMINOMETHYL)-4-(CARBOXYMETHYL)-1H-PYRROL-3-YL]PROPANOIC ACID | 組成式: | C10 H14 N2 O4 | SMILES: | O=C(O)CCc1c(c(nc1)CN)CC(=O)O | InChi: | InChI=1S/C10H14N2O4/c11-4-8-7(3-10(15)16)6(5-12-8)1-2-9(13)14/h5,12H,1-4,11H2,(H,13,14)(H,15,16) | 別名: | 2-AMINOMETHYLPYRROL-3-ACETIC ACID 4-PROPIONIC ACID | 定義日: | 2000-07-14 | 最終更新日: | 2020-06-17 | 識別子(ID): | 3-[5-(aminomethyl)-4-(carboxymethyl)-1H-pyrrol-3-yl]propanoic acid |
|
![DG7 DG7](https://data.pdbj.org/pdbjplus/data/cc/svg/DG7.svg) | DG7 | 表記: | 1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-{4-[2-(pyridin-3-ylmethoxy)ethyl]-1,3-thiazol-2-yl}urea | 組成式: | C26 H30 N6 O2 S | SMILES: | O=C(Nc1nc(cs1)CCOCc2cccnc2)Nc4cc(nn4c3ccc(cc3)C)C(C)(C)C | InChi: | InChI=1S/C26H30N6O2S/c1-18-7-9-21(10-8-18)32-23(14-22(31-32)26(2,3)4)29-24(33)30-25-28-20(17-35-25)11-13-34-16-19-6-5-12-27-15-19/h5-10,12,14-15,17H,11,13,16H2,1-4H3,(H2,28,29,30,33) | 別名: | 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-(pyridin-3-ylmethoxy)ethyl)thiazol-2-yl)urea | 定義日: | 2010-11-01 | 最終更新日: | 2020-06-17 | 識別子(ID): | 1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-{4-[2-(pyridin-3-ylmethoxy)ethyl]-1,3-thiazol-2-yl}urea |
|
![PD5 PD5](https://data.pdbj.org/pdbjplus/data/cc/svg/PD5.svg) | PD5 | 表記: | 1-{4-[4-amino-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]phenyl}-3-[3-(trifluoromethyl)phenyl]urea | 組成式: | C22 H20 F3 N7 O | SMILES: | FC(F)(F)c1cc(ccc1)NC(=O)Nc4ccc(c3nn(c2ncnc(c23)N)C(C)C)cc4 | InChi: | InChI=1S/C22H20F3N7O/c1-12(2)32-20-17(19(26)27-11-28-20)18(31-32)13-6-8-15(9-7-13)29-21(33)30-16-5-3-4-14(10-16)22(23,24)25/h3-12H,1-2H3,(H2,26,27,28)(H2,29,30,33) | 別名: | 1-(4-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-3-(3-(trifluoromethyl)phenyl)urea | 定義日: | 2008-10-06 | 最終更新日: | 2020-06-17 | 識別子(ID): | 1-{4-[4-amino-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]phenyl}-3-[3-(trifluoromethyl)phenyl]urea |
|
![PDG PDG](https://data.pdbj.org/pdbjplus/data/cc/svg/PDG.svg) | PDG | 表記: | N-({3-HYDROXY-2-METHYL-5-[(PHOSPHONOOXY)METHYL]PYRIDIN-4-YL}METHYL)-D-GLUTAMIC ACID | 組成式: | C13 H19 N2 O9 P | SMILES: | O=C(O)C(NCc1c(cnc(c1O)C)COP(=O)(O)O)CCC(=O)O | InChi: | InChI=1S/C13H19N2O9P/c1-7-12(18)9(8(4-14-7)6-24-25(21,22)23)5-15-10(13(19)20)2-3-11(16)17/h4,10,15,18H,2-3,5-6H2,1H3,(H,16,17)(H,19,20)(H2,21,22,23)/t10-/m1/s1 | 別名: | N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE | 定義日: | 2005-04-25 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-D-glutamic acid |
|
![TH9 TH9](https://data.pdbj.org/pdbjplus/data/cc/svg/TH9.svg) | TH9 | 表記: | (2Z)-4-({3-[3-(hexyloxy)phenyl]propyl}amino)-2-hydroxy-4-oxobut-2-enoic acid | 組成式: | C19 H27 N O5 | SMILES: | O=C(O)C(O)=CC(=O)NCCCc1cc(OCCCCCC)ccc1 | InChi: | InChI=1S/C19H27NO5/c1-2-3-4-5-12-25-16-10-6-8-15(13-16)9-7-11-20-18(22)14-17(21)19(23)24/h6,8,10,13-14,21H,2-5,7,9,11-12H2,1H3,(H,20,22)(H,23,24)/b17-14- | 別名: | BPH-1063 | 定義日: | 2011-08-24 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2Z)-4-({3-[3-(hexyloxy)phenyl]propyl}amino)-2-hydroxy-4-oxobut-2-enoic acid |
|
![QPP QPP](https://data.pdbj.org/pdbjplus/data/cc/svg/QPP.svg) | QPP | 表記: | N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE | 組成式: | C18 H15 N5 | SMILES: | n2c(Nc1nnc(c1)C)c4ccccc4nc2c3ccccc3 | InChi: | InChI=1S/C18H15N5/c1-12-11-16(23-22-12)20-18-14-9-5-6-10-15(14)19-17(21-18)13-7-3-2-4-8-13/h2-11H,1H3,(H2,19,20,21,22,23) | 別名: | 5,6-DIHYDRO-BENZO[H]CINNOLIN-3-YLAMINE | 定義日: | 2006-12-19 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-(5-methyl-1H-pyrazol-3-yl)-2-phenylquinazolin-4-amine |
|
![FEC FEC](https://data.pdbj.org/pdbjplus/data/cc/svg/FEC.svg) | FEC | 表記: | 1,3,5,8-TETRAMETHYL-PORPHINE-2,4,6,7-TETRAPROPIONIC ACID FERROUS COMPLEX | 組成式: | C36 H36 Fe N4 O8 | SMILES: | O=C(O)CCC1=C(C7=[N+]3C1=Cc5c(c(c6C=C8[N+]4=C(C=C2C(=C(C(N2[Fe]34n56)=C7)CCC(=O)O)C)C(=C8C)CCC(=O)O)C)CCC(=O)O)C | InChi: | InChI=1S/C36H38N4O8.Fe/c1-17-21(5-9-33(41)42)29-14-27-19(3)22(6-10-34(43)44)30(39-27)15-28-20(4)24(8-12-36(47)48)32(40-28)16-31-23(7-11-35(45)46)18(2)26(38-31)13-25(17)37-29 | 別名: | FE-COPROPORPHYRIN III | 定義日: | 2003-01-31 | 最終更新日: | 2020-06-17 | 識別子(ID): | [3,3',3'',3'''-(3,8,13,17-tetramethylporphyrin-2,7,12,18-tetrayl-kappa~4~N~21~,N~22~,N~23~,N~24~)tetrapropanoato(2-)]iron(2+) |
|
![G97 G97](https://data.pdbj.org/pdbjplus/data/cc/svg/G97.svg) | G97 | 表記: | N-[2-phenyl-4-(1H-pyrazol-3-ylamino)quinazolin-7-yl]prop-2-enamide | 組成式: | C20 H16 N6 O | SMILES: | O=C(C=C)Nc2ccc1c(nc(nc1c2)c3ccccc3)Nc4nncc4 | InChi: | InChI=1S/C20H16N6O/c1-2-18(27)22-14-8-9-15-16(12-14)23-19(13-6-4-3-5-7-13)25-20(15)24-17-10-11-21-26-17/h2-12H,1H2,(H,22,27)(H2,21,23,24,25,26) | 別名: | N-(4-(1H-pyrazol-3-ylamino)-2-phenylquinazolin-7-yl)acrylamide | 定義日: | 2009-06-16 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-[2-phenyl-4-(1H-pyrazol-3-ylamino)quinazolin-7-yl]prop-2-enamide |
|
![2XM 2XM](https://data.pdbj.org/pdbjplus/data/cc/svg/2XM.svg) | 2XM | 表記: | 2,2'-((4-(4-(((4,6-diaminopyrimidin-2-yl)thio)methyl)-5-propylthiazol-2-yl)-1,2-phenylene)bis(oxy))bis(ethan-1-ol) | 組成式: | C21 H27 N5 O4 S2 | SMILES: | OCCOc3c(OCCO)cc(c1nc(c(s1)CCC)CSc2nc(N)cc(n2)N)cc3 | InChi: | InChI=1S/C21H27N5O4S2/c1-2-3-17-14(12-31-21-25-18(22)11-19(23)26-21)24-20(32-17)13-4-5-15(29-8-6-27)16(10-13)30-9-7-28/h4-5,10-11,27-28H,2-3,6-9,12H2,1H3,(H4,22,23,25,26) | 別名: | 2,2'-{[4-(4-{[(4,6-diaminopyrimidin-2-yl)sulfanyl]methyl}-5-propyl-1,3-thiazol-2-yl)benzene-1,2-diyl]bis(oxy)}diethanol | 定義日: | 2014-04-08 | 最終更新日: | 2020-06-17 | 公開日: | 2014-11-05 | 識別子(ID): | 2,2'-{[4-(4-{[(4,6-diaminopyrimidin-2-yl)sulfanyl]methyl}-5-propyl-1,3-thiazol-2-yl)benzene-1,2-diyl]bis(oxy)}diethanol |
|
![2Y0 2Y0](https://data.pdbj.org/pdbjplus/data/cc/svg/2Y0.svg) | 2Y0 | 表記: | N-(2-(3-(4-(((4,6-diaminopyrimidin-2-yl)thio)methyl)-5-propylthiazol-2-yl)phenoxy)ethyl)methanesulfonamide | 組成式: | C20 H26 N6 O3 S3 | SMILES: | O=S(=O)(NCCOc1cccc(c1)c2nc(c(s2)CCC)CSc3nc(N)cc(n3)N)C | InChi: | InChI=1S/C20H26N6O3S3/c1-3-5-16-15(12-30-20-25-17(21)11-18(22)26-20)24-19(31-16)13-6-4-7-14(10-13)29-9-8-23-32(2,27)28/h4,6-7,10-11,23H,3,5,8-9,12H2,1-2H3,(H4,21,22,25,26) | 別名: | N-{2-[3-(4-{[(4,6-diaminopyrimidin-2-yl)sulfanyl]methyl}-5-propyl-1,3-thiazol-2-yl)phenoxy]ethyl}methanesulfonamide | 定義日: | 2014-04-09 | 最終更新日: | 2020-06-17 | 公開日: | 2015-02-18 | 識別子(ID): | N-{2-[3-(4-{[(4,6-diaminopyrimidin-2-yl)sulfanyl]methyl}-5-propyl-1,3-thiazol-2-yl)phenoxy]ethyl}methanesulfonamide |
|
![HE5 HE5](https://data.pdbj.org/pdbjplus/data/cc/svg/HE5.svg) | HE5 | 表記: | ZINC(II)-DEUTEROPORPHYRIN DIMETHYLESTER | 組成式: | C32 H34 N4 O4 Zn | SMILES: | COC(=O)CCc1c(C)c2C=C3C[CH](C)C4=Cc5cc(C)c6C=C7N8C(=Cc1n2[Zn]8(N34)n56)C(=C7C)CCC(=O)OC | InChi: | InChI=1S/C32H34N4O4.Zn/c1-17-11-22-14-27-19(3)23(7-9-31(37)39-5)29(35-27)16-30-24(8-10-32(38)40-6)20(4)28(36-30)15-26-18(2)12-21(34-26)13-25(17)33-22 | 別名: | ZND-DME | 定義日: | 2006-10-10 | 最終更新日: | 2020-06-17 |
|
![HEM HEM](https://data.pdbj.org/pdbjplus/data/cc/svg/HEM.svg) | HEM | 表記: | PROTOPORPHYRIN IX CONTAINING FE | 組成式: | C34 H32 Fe N4 O4 | SMILES: | C=1c3c(c(c4C=C5C(=C(C=6C=C7C(=C(C8=CC=2C(=C(C=1N=2[Fe](n34)(N5=6)N78)CCC(=O)O)C)C=C)C)C=C)C)C)CCC(=O)O | InChi: | InChI=1S/C34H34N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25 | 別名: | HEME | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | 3-[(5Z,10Z,14Z,19Z)-18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-21,23-dihydroporphyrin-2-yl]propanoic acid |
|
![ICD ICD](https://data.pdbj.org/pdbjplus/data/cc/svg/ICD.svg) | ICD | 表記: | 4-hydroxy-2-methyl-N-(5-methyl-1,2-oxazol-3-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide | 組成式: | C14 H13 N3 O5 S | SMILES: | O=C(C2=C(O)c1c(cccc1)S(=O)(=O)N2C)Nc3noc(c3)C | InChi: | InChI=1S/C14H13N3O5S/c1-8-7-11(16-22-8)15-14(19)12-13(18)9-5-3-4-6-10(9)23(20,21)17(12)2/h3-7,18H,1-2H3,(H,15,16,19) | 別名: | Isoxicam | 定義日: | 2013-08-09 | 最終更新日: | 2020-06-17 | 公開日: | 2014-01-22 | 識別子(ID): | 4-hydroxy-2-methyl-N-(5-methyl-1,2-oxazol-3-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide |
|
![11W 11W](https://data.pdbj.org/pdbjplus/data/cc/svg/11W.svg) | 11W | 表記: | (4R)-4-[(2E)-3-{4-[(E)-phenyldiazenyl]phenyl}prop-2-en-1-yl]-L-glutamic acid | 組成式: | C20 H21 N3 O4 | SMILES: | O=C(O)C(N)CC(C(=O)O)C/C=C/c2ccc(/N=N/c1ccccc1)cc2 | InChi: | InChI=1S/C20H21N3O4/c21-18(20(26)27)13-15(19(24)25)6-4-5-14-9-11-17(12-10-14)23-22-16-7-2-1-3-8-16/h1-5,7-12,15,18H,6,13,21H2,(H,24,25)(H,26,27)/b5-4+,23-22+/t15-,18+/m1/s1 | 別名: | trans-GluAzo | 定義日: | 2012-10-01 | 最終更新日: | 2020-06-17 | 公開日: | 2013-09-25 | 識別子(ID): | (4R)-4-[(2E)-3-{4-[(E)-phenyldiazenyl]phenyl}prop-2-en-1-yl]-L-glutamic acid |
|
![18B 18B](https://data.pdbj.org/pdbjplus/data/cc/svg/18B.svg) | 18B | 表記: | 3-[2-[(Z)-[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-pyrrol-2-ylidene]methy
l]-5-[(Z)-(4-ethyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid | 組成式: | C33 H36 N4 O6 | SMILES: | CCC1=C(C)C(NC1=O)=Cc2[nH]c(C=C3N=C(C=C4NC(=O)C(=C4C=C)C)C(=C3CCC(O)=O)C)c(CCC(O)=O)c2C | InChi: | InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7,13-15,34H,1,8-12H2,2-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-,29-15- | 別名: | 181,182-dihydrobiliverdin | 定義日: | 2009-08-04 | 最終更新日: | 2020-06-17 | 識別子(ID): | 3-[2-[(Z)-[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-pyrrol-2-ylidene]methyl]-5-[(Z)-(4-ethyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid |
|
![MXM MXM](https://data.pdbj.org/pdbjplus/data/cc/svg/MXM.svg) | MXM | 表記: | 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide | 組成式: | C14 H13 N3 O4 S2 | SMILES: | O=C(Nc1ncc(s1)C)C3=C(O)c2ccccc2S(=O)(=O)N3C | InChi: | InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19) | 別名: | Meloxicam | 定義日: | 2013-08-09 | 最終更新日: | 2020-06-17 | 公開日: | 2014-01-22 | 識別子(ID): | 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide |
|
![04A 04A](https://data.pdbj.org/pdbjplus/data/cc/svg/04A.svg) | 04A | 表記: | N,N'-[sulfanediylbis(ethane-2,1-diyl-1,3,4-thiadiazole-5,2-diyl)]bis(2-phenylacetamide) | 組成式: | C24 H24 N6 O2 S3 | SMILES: | O=C(Nc1nnc(s1)CCSCCc2nnc(s2)NC(=O)Cc3ccccc3)Cc4ccccc4 | InChi: | InChI=1S/C24H24N6O2S3/c31-19(15-17-7-3-1-4-8-17)25-23-29-27-21(34-23)11-13-33-14-12-22-28-30-24(35-22)26-20(32)16-18-9-5-2-6-10-18/h1-10H,11-16H2,(H,25,29,31)(H,26,30,32) | 別名: | BPTES | 定義日: | 2011-11-22 | 最終更新日: | 2020-06-17 | 識別子(ID): | N,N'-[sulfanediylbis(ethane-2,1-diyl-1,3,4-thiadiazole-5,2-diyl)]bis(2-phenylacetamide) |
|
![NTE NTE](https://data.pdbj.org/pdbjplus/data/cc/svg/NTE.svg) | NTE | 表記: | [3,3'-{7-ethenyl-3,8,13,17-tetramethyl-12-[(E)-2-nitroethenyl]porphyrin-2,18-diyl-kappa~4~N~21~,N~22~,N~23~,N~24~}dipro
panoato(2-)]iron | 組成式: | C34 H31 Fe N5 O6 | SMILES: | N45[Fe]26n1c8c(c(c1C=C3N2=C(C(=C3C)C=C[N+]([O-])=O)C=C4C(=C(C5=CC7=N6C(C(=C7C)CCC(=O)O)=C8)C=C)C)C)CCC(O)=O | InChi: | InChI=1S/C34H33N5O6.Fe/c1-6-21-17(2)27-15-30-24(11-12-39(44)45)20(5)26(36-30)13-25-18(3)22(7-9-33(40)41)31(37-25)16-32-23(8-10-34(42)43)19(4)28(38-32)14-29(21)35-27 | 別名: | Nitriheme | 定義日: | 2011-03-02 | 最終更新日: | 2020-06-17 | 識別子(ID): | {3,3'-[7-ethenyl-3,8,13,17-tetramethyl-12-(2-nitroethenyl)porphyrin-2,18-diyl-kappa~4~N~21~,N~22~,N~23~,N~24~]dipropanoato(2-)}iron |
|
![92M 92M](https://data.pdbj.org/pdbjplus/data/cc/svg/92M.svg) | 92M | 表記: | 9-cyclopentyl-2-(4-(4-hydroxypiperidin-1-yl)-2-methoxyphenylamino)-5-methyl-8,9-dihydro-5H-pyrimido[4,5-b][1,4]diazepin
-6(7H)-one | 組成式: | C25 H34 N6 O3 | SMILES: | O=C4N(c1c(nc(nc1)Nc3ccc(N2CCC(O)CC2)cc3OC)N(CC4)C5CCCC5)C | InChi: | InChI=1S/C25H34N6O3/c1-29-21-16-26-25(28-24(21)31(14-11-23(29)33)17-5-3-4-6-17)27-20-8-7-18(15-22(20)34-2)30-12-9-19(32)10-13-30/h7-8,15-17,19,32H,3-6,9-14H2,1-2H3,(H,26,27,28) | 別名: | 9-cyclopentyl-2-{[4-(4-hydroxypiperidin-1-yl)-2-methoxyphenyl]amino}-5-methyl-5,7,8,9-tetrahydro-6H-pyrimido[4,5-b][1,4
]diazepin-6-one | 定義日: | 2009-05-05 | 最終更新日: | 2020-06-17 | 識別子(ID): | 9-cyclopentyl-2-{[4-(4-hydroxypiperidin-1-yl)-2-methoxyphenyl]amino}-5-methyl-5,7,8,9-tetrahydro-6H-pyrimido[4,5-b][1,4]diazepin-6-one |
|
![ALH ALH](https://data.pdbj.org/pdbjplus/data/cc/svg/ALH.svg) | ALH | 表記: | 6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE | 組成式: | C16 H17 N3 O | SMILES: | n1c3c(ncc1)c(c(c2ccc(O)cc2)n3)CCCC | InChi: | InChI=1S/C16H17N3O/c1-2-3-4-13-14(11-5-7-12(20)8-6-11)19-16-15(13)17-9-10-18-16/h5-10,20H,2-4H2,1H3,(H,18,19) | 別名: | ALOISINE A | 定義日: | 2003-09-09 | 最終更新日: | 2020-06-17 | 識別子(ID): | 4-(7-butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol |
|
![ATV ATV](https://data.pdbj.org/pdbjplus/data/cc/svg/ATV.svg) | ATV | 表記: | 2-[(2R)-oxiran-2-ylmethyl]-1H-benzo[de]isoquinoline-1,3(2H)-dione | 組成式: | C15 H11 N O3 | SMILES: | O=C1N(C[CH]2CO2)C(=O)c3cccc4cccc1c34 | InChi: | InChI=1S/C15H11NO3/c17-14-11-5-1-3-9-4-2-6-12(13(9)11)15(18)16(14)7-10-8-19-10/h1-6,10H,7-8H2/t10-/m1/s1 | 別名: | N-(2,3-epoxypropyl)-1,8-naphthalimide | 定義日: | 2009-12-04 | 最終更新日: | 2020-06-17 |
|
![BFB BFB](https://data.pdbj.org/pdbjplus/data/cc/svg/BFB.svg) | BFB | 表記: | N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE | 組成式: | C14 H20 N4 O2 | SMILES: | O=C(NC(C(=O)N)CCCNC(=[N@H])C)c1ccccc1 | InChi: | InChI=1S/C14H20N4O2/c1-10(15)17-9-5-8-12(13(16)19)18-14(20)11-6-3-2-4-7-11/h2-4,6-7,12H,5,8-9H2,1H3,(H2,15,17)(H2,16,19)(H,18,20)/t12-/m0/s1 | 別名: | (S)-N-ALPHA-BENZOYL-N5-(2-FLUORO-1-IMINOETHYL)-L-ORNITHINE AMIDE | 定義日: | 2006-08-09 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-{(1S)-1-carbamoyl-4-[(1Z)-ethanimidoylamino]butyl}benzamide |
|
![BK7 BK7](https://data.pdbj.org/pdbjplus/data/cc/svg/BK7.svg) | BK7 | 表記: | 3-(6-ethoxynaphthalen-2-yl)-1-(piperidin-4-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | 組成式: | C23 H26 N6 O | SMILES: | n1c(c2c(nc1)n(nc2c4cc3ccc(OCC)cc3cc4)CC5CCNCC5)N | InChi: | InChI=1S/C23H26N6O/c1-2-30-19-6-5-16-11-18(4-3-17(16)12-19)21-20-22(24)26-14-27-23(20)29(28-21)13-15-7-9-25-10-8-15/h3-6,11-12,14-15,25H,2,7-10,13H2,1H3,(H2,24,26,27) | 別名: | RM-1-132 | 定義日: | 2011-07-27 | 最終更新日: | 2020-06-17 | 識別子(ID): | 3-(6-ethoxynaphthalen-2-yl)-1-(piperidin-4-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
|